Platelet-derived CXC chemokines: old players in new games

被引:136
|
作者
Brandt, E [1 ]
Ludwig, A [1 ]
Petersen, F [1 ]
Flad, HD [1 ]
机构
[1] Res Ctr Borstel, Dept Immunol & Cell Biol, D-23845 Borstel, Germany
关键词
D O I
10.1034/j.1600-065X.2000.17705.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although platelet factor 4 (PF-4) and the beta -thromboglobulin (beta -TG) proteins represent the first chemokines to be discovered, their functional roles in host defense became clear only recently. Residing in platelets as storage proteins and becoming released into the blood at very high concentrations, these mediators appear to fulfill different and complementary tasks as first-line mediators in the recruitment and activation of leukocytes, as well in the regulation of tissue repair. Whereas both proteins are structurally closely related members of the CXC chemokine subfamily, they are subject to quite dissimilar regulatory mechanisms controlling their generation and their spectrum of biological activities. Thus, proteolytic processing of inactive precursors plays a decisive role in whether the beta -TG proteins will act as stimulatory or inhibitory agents in neutrophil activation via the G protein-coupled receptors CXCR-1 and 2. PF-4, existing as a single molecular form, is largely resistant to proteolytic modification, but its interaction with an unusual recepror(s) on leukocytes (a proteoglycan) appears to depend on its oligomeric stare. There is growing evidence that both chemokines may interfere with each other at various regulatory levels to promote coordinated cell activation. Moreover, recent findings suggest novel and unexpected activities for these chemokines, which may extend our view on early host defense.
引用
收藏
页码:204 / 216
页数:13
相关论文
共 50 条
  • [1] The heterodimerization of platelet-derived chemokines
    Carlson, James
    Baxter, Sarah A.
    Dreau, Didier
    Nesmelova, Irina V.
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2013, 1834 (01): : 158 - 168
  • [2] Platelet-derived chemokines in atherosclerosis
    Duchene, J.
    von Hundelshausen, P.
    HAMOSTASEOLOGIE, 2015, 35 (02): : 137 - +
  • [3] Platelet-Derived Chemokines in Atherogenesis: What's New?
    Gleissner, Christian A.
    CURRENT VASCULAR PHARMACOLOGY, 2012, 10 (05) : 563 - 569
  • [4] The β-thromboglobulins and platelet factor 4:: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation
    Brandt, E
    Petersen, F
    Ludwig, A
    Ehlert, JE
    Bock, L
    Flad, HD
    JOURNAL OF LEUKOCYTE BIOLOGY, 2000, 67 (04) : 471 - 478
  • [5] Platelet-derived chemokines in vascular biology
    von Hundelshausen, Philipp
    Petersen, Frank
    Brandt, Ernst
    THROMBOSIS AND HAEMOSTASIS, 2007, 97 (05) : 704 - 713
  • [6] Platelet-derived chemokines in inflammation and atherosclerosis
    Bakogiannis, Constantinos
    Sachse, Marco
    Stamatelopoulos, Kimon
    Stellos, Konstantinos
    CYTOKINE, 2019, 122
  • [7] Platelet-derived chemokines: New targets to treat liver fibrosis
    Morales-Ibanez, Oriol
    Bataller, Ramon
    JOURNAL OF HEPATOLOGY, 2011, 54 (03) : 581 - 583
  • [8] Platelet-Derived Chemokines in Vascular Remodeling and Atherosclerosis
    Koenen, Rory R.
    Weber, Christian
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2010, 36 (02): : 163 - 169
  • [9] Platelet-derived chemokines: pathophysiology and therapeutic aspects
    Flad, Hans-Dieter
    Brandt, Ernst
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2010, 67 (14) : 2363 - 2386
  • [10] Platelet-derived chemokines: pathophysiology and therapeutic aspects
    Hans-Dieter Flad
    Ernst Brandt
    Cellular and Molecular Life Sciences, 2010, 67 : 2363 - 2386